超声引导下甲状腺结节粗针活检并发症的系统评价与Meta分析
该系统评价与Meta分析检索1994年1月1日至2016年12月13日文献,纳入39篇研究共14818例患者,评估超声引导下甲状腺病变粗针活检的并发症发生率。粗针活检总体并发症合并比例为1.11%(95%CI 0.64-1.51,I²=87.2%),主要并发症为0.06%(95%CI 0.02-0.10,I²=0.0%)远低于次要并发症的1.08%(95%CI 0.63-1.53,I²=93.17%);亚组分析各比较组间无显著差异。作者结论认为该操作安全、并发症发生率低。
要点
- 超声引导下甲状腺病变粗针活检总体并发症合并比例为1.11%(95%CI 0.64-1.51,I²=87.2%)。
- 主要并发症合并比例0.06%(95%CI 0.02-0.10,I²=0.0%)远低于次要并发症1.08%(95%CI 0.63-1.53,I²=93.17%)。
- 亚洲与非亚洲、放射科医师与非放射科医师、结节<20 mm与≥20 mm、粗针活检与粗针活检联合细针穿刺、2012年前后各组间均无显著差异。
核心结论
- 超声引导下甲状腺病变粗针活检后可发生各种并发症,但该操作安全,并发症发生率低。
研究设计与样本
- 系统评价与Meta分析,检索Ovid-MEDLINE和EMBASE数据库1994年1月1日至2016年12月13日关于超声引导下甲状腺病变粗针活检的研究。
- 从393篇潜在文献中纳入39篇合格文献,共14818例患者。
- 采用随机效应模型评估并发症合并比例,并进行亚组分析;采用χ²统计量和不一致性指数I²探讨研究间异质性;采用非随机研究偏倚风险评估工具评价研究质量。
诊断标准与关键数值
- 粗针活检后总体并发症合并比例为1.11%(95%CI 0.64-1.51,I²=87.2%)。
- 主要并发症合并比例为0.06%(95%CI 0.02-0.10,I²=0.0%)。
- 次要并发症合并比例为1.08%(95%CI 0.63-1.53,I²=93.17%)。
- 亚组分析显示亚洲组与非亚洲组(p=0.7769)、放射科医师组与非放射科医师组(p=0.8607)、结节<20 mm组与结节≥20 mm组(p=0.1591)、粗针活检组与粗针活检联合细针穿刺组(p=0.9281)、2012年前与2012年后研究组(p=0.6251)之间均无显著差异。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 总体并发症合并比例的异质性I²=87.2%,次要并发症合并比例的异质性I²=93.17%。
- 纳入研究的总体质量为中等,所有研究满足8个总域中的5个或以上。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify the complication rate associated with US-guided core needle biopsy (CNB) of thyroid lesions using a systematic review and meta-analysis.
METHODS: Ovid-MEDLINE and EMBASE databases were searched for studies on US-guided CNB of thyroid lesions from 1 January 1994-13 December 2016. A review of 393 potential papers identified 39 eligible papers including 14,818 patients. The pooled proportions of complications were assessed using random-effects modelling. Subgroup analysis was performed. Among-study heterogeneity was explored using χ2 statistic for pooled estimates and inconsistency index I2. Quality of the studies was evaluated using the Risk of Bias Assessment Tool for Nonrandomized Studies.
RESULTS: The pooled proportion of overall complications after CNB of thyroid lesions was 1.11% (95% CI: 0.64-1.51, I2: 87.2%). The pooled proportion of major complications (0.06% [95% CI: 0.02-0.10], I2: 0.0%) was much lower than that of minor complications (1.08%[95% CI: 0.63-1.53], I2: 93.17%). Subgroup analysis revealed no significant differences between studies on Asian versus non-Asian groups (p=0.7769), radiologist versus non-radiologist groups (p=0.8607), nodule size <20 mm versus nodule size ≥20 mm (p=0.1591) groups, CNB versus CNB-plus-FNA groups (p=0.9281) and studies performed before and after 2012 (p=0.6251). The overall quality of the included studies was moderate with all of the studies satisfying five or more of the eight total domains.
CONCLUSION: Various complications can occur after US-guided CNB of thyroid lesions. However, the procedure is safe, with a low complication rate.
KEY POINTS: • Various complications occurred after CNB of thyroid lesions, but the pooled complication rate was low (1.11%, I 2 = 87.2%). • The pooled proportion of major complications (0.06%) was much lower than that of minor complications (1.08%). • There was no significant differences between studies on Asian vs. non-Asian groups, radiologist vs. non-radiologist groups, nodule size <20 mm vs. nodule size ≥20 mm groups, CNB vs. CNB-plus-FNA groups, or studies performed before 2012 vs. after 2012.
引用
- Ha EJ, Suh CH, Baek JH, et al. Complications following ultrasound-guided core needle biopsy of thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2018. PMID: 29589112. doi:10.1007/s00330-018-5367-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。